{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:51:32Z","timestamp":1788288692267,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":108,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013703","name":"Royal Osteoporosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007863","name":"Rice University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000324","name":"Gatsby Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000377","name":"Dunhill Medical Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000550","name":"British Geriatrics Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.prdoa.2025.100334","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T09:58:29Z","timestamp":1745143109000},"page":"100334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nocturnal polyuria is common in Parkinson\u2019s and is associated with orthostatic hypotension"],"prefix":"10.1016","volume":"12","author":[{"given":"Matthew D","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella E","family":"Portlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-3007","authenticated-orcid":false,"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prdoa.2025.100334_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.995850","article-title":"Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100334_b0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.euf.2022.01.007","article-title":"Evaluation and treatment in urology for nocturia caused by nonurological mechanisms: guidance from the PLANET study","volume":"8","author":"Smith","year":"2022","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.prdoa.2025.100334_b0015","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/nau.22609","article-title":"Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013","volume":"33","author":"Drake","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.prdoa.2025.100334_b0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/nau.22219","article-title":"Nocturia think tank: focus on nocturnal polyuria: ICI-RS 2011","volume":"31","author":"Weiss","year":"2012","journal-title":"Neurourol. Urodyn."},{"issue":"2","key":"10.1016\/j.prdoa.2025.100334_b0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mdc3.12279","article-title":"Nocturia in patients with Parkinson\u2019s disease","volume":"3","author":"Smith","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100334_b0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.purol.2015.02.004","article-title":"Is nocturnal polyuria more frequent among patients with Parkinson\u2019s disease?","volume":"25","author":"Romain","year":"2015","journal-title":"Prog. Urol."},{"issue":"3","key":"10.1016\/j.prdoa.2025.100334_b0035","first-page":"583","article-title":"Day-night variation of urine volume in Parkinson\u2019s disease","volume":"48","author":"Hineno","year":"1994","journal-title":"Jpn. J. Psychiatry Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100334_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-022-06827-3","article-title":"Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson\u2019s Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson\u2019s disease using a self-contained wearable device","volume":"23","author":"Smith","year":"2022","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.prdoa.2025.100334_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057947","article-title":"Needs of patients with parkinsonism and their caregivers: a protocol for the PRIME-UK cross-sectional study","volume":"12","author":"Tenison","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.prdoa.2025.100334_b0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/nau.22436","article-title":"Pad weight testing in the evaluation of urinary incontinence","volume":"33","author":"Krhut","year":"2014","journal-title":"Neurourol. Urodyn."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100334_b0055","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0022-5347(05)66926-1","article-title":"Scoring the short form ICSmale SF questionnaire","volume":"164","author":"Donovan","year":"2000","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100334_b0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1464-410X.1996.00186.x","article-title":"The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing","volume":"77","author":"Jackson","year":"1996","journal-title":"Br. J. Urol."},{"issue":"11","key":"10.1016\/j.prdoa.2025.100334_b0065","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.20153","article-title":"Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT","volume":"19","author":"Visser","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100334_b0070","doi-asserted-by":"crossref","unstructured":"K. Coyne et al., \u201cPsychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q,\u201d pp. 563\u2013574, 2002.","DOI":"10.1023\/A:1016370925601"},{"key":"10.1016\/j.prdoa.2025.100334_b0075","doi-asserted-by":"crossref","unstructured":"C.G. Goetz et al., \u201cMovement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results,\u201d 23(15) 2008 2129\u20132170, doi: 10.1002\/mds.22340.","DOI":"10.1002\/mds.22340"},{"issue":"2","key":"10.1016\/j.prdoa.2025.100334_b0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.prdoa.2025.100334_b0085","doi-asserted-by":"crossref","unstructured":"A. Fanciulli et al., \u201cConsensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH),\u201d Aug. 01, 2018, Dr. Dietrich Steinkopff Verlag GmbH and Co. KG. doi: 10.1007\/s10286-018-0529-8.","DOI":"10.1007\/s10286-018-0529-8"},{"issue":"2","key":"10.1016\/j.prdoa.2025.100334_b0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/nau.23917","article-title":"International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function","volume":"38","author":"Hashim","year":"2019","journal-title":"Neurourol. Urodyn."},{"issue":"Suppl 3","key":"10.1016\/j.prdoa.2025.100334_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1464-410X.90.s3.3.x","article-title":"The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society","volume":"90","author":"Van Kerrebroeck","year":"2002","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.prdoa.2025.100334_b0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.eururo.2012.10.004","article-title":"Prevalence, incidence, and resolution of nocturnal polyuria in a longitudinal community-based study in older men: the Krimpen study","volume":"63","author":"Van Doorn","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prdoa.2025.100334_b0105","article-title":"Implications of cardiovascular disease for assessment and treatment of nocturia in primary care; systematic review and nominal group technique consensus","author":"Bueno Garcia Reyes","year":"2021","journal-title":"Eur. Urol. Focus"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100334_b0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euf.2021.12.014","article-title":"Implications of cardiovascular disease for assessment and treatment of Nocturia in primary care: systematic review and nominal group technique consensus","volume":"8","author":"Reyes","year":"2022","journal-title":"Eur. Urol. Focus"},{"issue":"2","key":"10.1016\/j.prdoa.2025.100334_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm11020129","article-title":"Blood pressure patterns in patients with parkinson\u2019s disease: a systematic review","volume":"11","author":"Tulb\u0103","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.prdoa.2025.100334_b0120","doi-asserted-by":"crossref","unstructured":"J.G. Johnston, D.M. Pollock. \u201cCircadian regulation of renal function,\u201d May 01, 2018, Elsevier Inc. doi: 10.1016\/j.freeradbiomed.2018.01.018.","DOI":"10.1016\/j.freeradbiomed.2018.01.018"},{"key":"10.1016\/j.prdoa.2025.100334_b0125","doi-asserted-by":"crossref","unstructured":"O.R. Tamtaji, R.J. Reiter, R. Alipoor, E. Dadgostar, E. Kouchaki, Z. Asemi. \u201cMelatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms,\u201d Jan. 01, 2020, Springer. doi: 10.1007\/s10571-019-00720-5.","DOI":"10.1007\/s10571-019-00720-5"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100334_b0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/sleep\/14.1.83","article-title":"Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome","volume":"14","author":"Baruzzi","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.prdoa.2025.100334_b0135","doi-asserted-by":"crossref","unstructured":"G. Maggi, C. Giacobbe, F. Iannotta, G. Santangelo, C. Vitale. \u201cPrevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: a meta-analysis,\u201d Feb. 01, 2024, John Wiley and Sons Inc. doi: 10.1111\/ene.16109.","DOI":"10.1111\/ene.16109"},{"issue":"4","key":"10.1016\/j.prdoa.2025.100334_b0140","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.juro.2013.10.100","article-title":"The association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta-analyses","volume":"191","author":"Hofmeester","year":"2014","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.prdoa.2025.100334_b0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1464-410X.2012.11749.x","article-title":"The New England Research Institutes, Inc. (NERI) Nocturia advisory conference 2012: focus on outcomes of therapy","volume":"111","author":"Weiss","year":"2013","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.prdoa.2025.100334_b0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson\u2019s disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100334_b0155","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ene.14774","article-title":"Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson\u2019s disease","volume":"28","author":"Batla","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"September","key":"10.1016\/j.prdoa.2025.100334_b0160","first-page":"1","article-title":"Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: a systematic review and meta-analysis","author":"Hajebrahimi","year":"2023","journal-title":"Neurourol. Urodyn."},{"issue":"3","key":"10.1016\/j.prdoa.2025.100334_b0165","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.juro.2012.12.112","article-title":"Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study","volume":"190","author":"Weiss","year":"2013","journal-title":"J. Urol."}],"container-title":["Clinical Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:19:03Z","timestamp":1775819943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112525000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"alternative-id":["S2590112525000386"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100334","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nocturnal polyuria is common in Parkinson\u2019s and is associated with orthostatic hypotension","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100334"}}